Cognition Therapeutics (CGTX) CEO Lisa Ricciardi Buys Stock

What Happened
Lisa Ricciardi, CEO, President and a director of Cognition Therapeutics, purchased 9,175 shares of CGTX in an open-market transaction on April 16, 2026. The shares were bought at $1.10 each for a total reported cost of $10,093. This was a purchase (insider acquisition), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date and price: 2026-04-16 — 9,175 shares at $1.10 per share.
• Total value: $10,093.
• Transaction type: Open-market purchase (Form 4 code P).
• Shares owned after the transaction: Not specified in the filing provided.
• Footnotes/plan: No 10b5-1 plan or other special instruction referenced in the provided details.
• Filing timeliness: Report filed 2026-04-20; appears to be filed on time (within the required two business days).

Context
Insider purchases can be interpreted as a positive signal, but this one is relatively small ($~10k), so its informational weight is limited. No additional details (e.g., ongoing trading plan or larger holdings change) were disclosed in the provided filing.